HCM

Dopo l'orario di chiusura: 15.36 -0.06 -0.39%

Hutchmed China Limited Adr (HCM)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Forum Previsione

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Hutchmed China Limited Adr Stock (HCM) Company Profile

Hutchmed China Limited Adr

Healthcare (1118)

Prossima data di guadagno

Ultimi documenti SEC

HCM's Discussions on Twitter

Compare HCM vs TAK, ZTS, HLN, TEVA, UTHR

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
HCM Hutchmed China Limited Adr	15.42	2.65B	549.97M	458.86M	-89.06M	2.6236
TAK Takeda Pharmaceutical Co Adr	18.74	59.20B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	117.94	49.79B	9.47B	2.67B	2.28B	6.0218
HLN Haleon Plc Adr	9.93	44.27B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	30.08	35.03B	17.41B	1.43B	1.00B	1.2182
UTHR United Therapeutics Corp	564.81	24.75B	3.18B	1.33B	1.04B	27.90

Hutchmed China Limited Adr Stock (HCM) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-09-22	Downgrade	Morgan Stanley	Equal-Weight → Underweight
2025-05-13	Downgrade	HSBC Securities	Buy → Hold
2023-11-24	Aggiornamento	Deutsche Bank	Hold → Buy
2022-05-04	Downgrade	Deutsche Bank	Buy → Hold
2021-09-22	Downgrade	Goldman	Buy → Neutral
2021-08-03	Iniziato	Jefferies	Buy
2020-10-02	Iniziato	Deutsche Bank	Buy
2020-03-13	Iniziato	Cantor Fitzgerald	Overweight
2020-02-20	Iniziato	Goldman	Buy
2019-11-19	Iniziato	CLSA	Buy
2019-10-23	Reiterato	BofA/Merrill	Buy
2019-07-05	Iniziato	Macquarie	Outperform

Mostra tutto

Hutchmed China Limited Adr Borsa (HCM) Ultime notizie

Hutchmed China Limited Adr Azioni (HCM) Dati Finanziari

Hutchmed China Limited Adr (HCM)

Hutchmed China Limited Adr Stock (HCM) Company Profile

Compare HCM vs TAK, ZTS, HLN, TEVA, UTHR

Hutchmed China Limited Adr Stock (HCM) Upgrades & Downgrades

Hutchmed China Limited Adr Borsa (HCM) Ultime notizie

Takeda Pharmaceutical Company Limited (TAK) stock price, news, quote and history - Yahoo Finance Singapore

Takeda Pharmaceutical Company Limited (TAK) Stock Price, News, Quote & History - Yahoo Finance

Zai Lab Limited (ZLAB) stock price, news, quote and history - Yahoo Finance UK

Short Interest in HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM) Decreases By 13.7% - MarketBeat

HUTCHMED (NASDAQ:HCM) Shares Gap UpTime to Buy? - MarketBeat

HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat

HUTCHMED (NASDAQ:HCM) Stock Price Crosses Below 50-Day Moving AverageHere's Why - MarketBeat

HUTCHMED (Nasdaq: HCM) launches registrational Phase III HMPL-760 lymphoma trial in China - Stock Titan

HUTCHMED Initiates Phase III Trial of HMPL-760 in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma in China - GlobeNewswire Inc.

HUTCHMED (HCM) vests 19,913 LTIP shares for CEO Dr. Weiguo Su - Stock Titan

HUTCHMED (China) Limited Sponsored ADR $HCM Stake Trimmed by Schroder Investment Management Group - MarketBeat

HUTCHMED (LON:HCM) Share Price Crosses Below 200-Day Moving Average – Time to Sell? - Defense World

HUTCHMED (HCM) vests 726,317 LTIP shares to CEO and CFO - Stock Titan

TAZVERIK cancer drug withdrawn; HUTCHMED (HCM) ends China trials - Stock Titan

CLSA Cuts TP of HUTCHMED (00013.HK) to HKD30.4; Rating Outperform - AASTOCKS.com

Intended Retirement of Independent Non-executive Director and changes of composition of board committees - ChartMill

HUTCHMED (NASDAQ: HCM) plans INED retirement, reshapes board roles - Stock Titan

HUTCHMED H2 Earnings Call Highlights - Yahoo Finance

Food & Life Companies (3563.JP) Plunges 14% Following Alleged Parasite Egg Discovery at Beijing's Sushiro - AASTOCKS.com

[6-K] HUTCHMED (China) Ltd Current Report (Foreign Issuer) | HCM SEC FilingForm 6-K - Stock Titan

HUTCHMED Reports 2025 Full Year Results and Business Updates - GlobeNewswire

HUTCHMED (LON:HCM) Share Price Crosses Below 200-Day Moving Average – What’s Next? - Defense World

Brokerages Set QCR Holdings, Inc. (NASDAQ:QCRH) PT at $102.25 - Defense World

Adtalem Global Education Inc. (NYSE:ATGE) Receives $151.50 Average PT from Analysts - Defense World

HUTCHMED Initiates Global Trial of PI3K/PIKK-EGFR ATTC Candidate HMPL-A580 in Patients with Solid Tumors - GlobeNewswire

HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM) Receives Average Rating of "Hold" from Analysts - MarketBeat

HUTCHMED (NASDAQ:HCM) Stock Crosses Below 50 Day Moving AverageHere's What Happened - MarketBeat

JPMorgan Chase & Co. Has $729.86 Million Stock Holdings in iShares ESG Aware MSCI EAFE ETF $ESGD - Defense World

Glenview Trust Co Raises Stock Position in Vanguard Intermediate-Term Corporate Bond ETF $VCIT - Defense World

HUTCHMED (NASDAQ:HCM) Shares Pass Above Fifty Day Moving AverageHere's Why - MarketBeat

UOB Kay Hian Favors ALI HEALTH, PA GOODDOCTOR; AI Innovation & National Policies Drive CN Internet Healthcare Sector - AASTOCKS.com

Labcorp Holdings Inc. $LH Stake Lessened by Jensen Investment Management Inc. - Defense World

Kayne Anderson Energy Infrastructure Fund (NYSE:KYN) Share Price Crosses Above Two Hundred Day Moving Average – What’s Next? - Defense World

Cipher Mining (NASDAQ:CIFR) Shares Gap Up – Still a Buy? - Defense World

Brokerages Set HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM) PT at $20.88 - Defense World

BOCOMI Expects Pharma Sector to Continue Stable Improvement This Yr, Recommends Seeking Undervalued Pharma - AASTOCKS.com

HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM) Short Interest Down 12.6% in January - MarketBeat

Paycom Software, Inc. (PAYC): A Bull Case Theory - Finviz

HUTCHMED (NASDAQ:HCM) Sees Unusually-High Trading VolumeShould You Buy? - MarketBeat

HUTCHMED Highlights Publication of Phase III SACHI Results in The Lancet - The Manila Times

D.A. Davidson & CO. Reduces Stock Holdings in MP Materials Corp. $MP - Defense World

Dynavax Technologies Corporation (NASDAQ:DVAX) Receives Average Rating of “Hold” from Brokerages - Defense World

HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM) Given Average Recommendation of “Hold” by Analysts - Defense World

Bausch Health Cos Inc. (NYSE:BHC) Given Consensus Rating of “Hold” by Analysts - Defense World

Urban Edge Properties (NYSE:UE) Given Consensus Recommendation of “Hold” by Brokerages - Defense World

Hawaiian Electric Industries, Inc. (NYSE:HE) Given Consensus Rating of “Hold” by Analysts - Defense World

Compass Diversified Holdings (NYSE:CODI) Given Consensus Recommendation of “Hold” by Brokerages - Defense World

HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM) Given Average Recommendation of "Hold" by Analysts - MarketBeat

Automatic Data Processing (NASDAQ:ADP) VP Sells $234,000.00 in Stock - Defense World

Why HUTCHMED (China) Limited Depositary Receipt stock could see breakout soonJuly 2025 Intraday Action & Stepwise Trade Execution Plans - ulpravda.ru

Wall Street Analysts Predict a 55.93% Upside in HUTCHMED (HCM): Here's What You Should Know - Finviz

Hutchmed China Limited Adr Azioni (HCM) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a HCM